United Drug is a healthcare services provider. The Company has four segments: Pharma Wholesale, Supply Chain Services, Medical and Scientific, and Contract Sales and Marketing Services.United Drug provides commercialisation solutions to international healthcare companies. We specialise in supply chain, packaging, sales and marketing, medical and regulatory services. We operate in five major international markets, and employ over 7,000 people around the world
15:20 04/04/2017
Broker Forecast - Numis issues a broker note on UDG Healthcare PLC
Numis today downgrades its investment rating on UDG Healthcare PLC (LON:UDG) to hold (from add) and left its price target at 730p. Story provided by StockMarketWire.com
12:30 04/04/2017
Broker Forecast - Stifel issues a broker note on UDG Healthcare PLC
Stifel today reaffirms its hold investment rating on UDG Healthcare PLC (LON:UDG) and raised its price target to 650p (from 620p). Story provided by StockMarketWire.com
13:00 07/02/2018
Broker Forecast - N+1 Singer issues a broker note on UDG Healthcare PLC
N+1 Singer today reaffirms its hold investment rating on UDG Healthcare PLC (LON:UDG) and set its price target at 813p. Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk
08:30 07/02/2018
Broker Forecast - Liberum Capital issues a broker note on UDG Healthcare PLC
Liberum Capital today upgrades its investment rating on UDG Healthcare PLC (LON:UDG) to buy (from hold) and left its price target at 884p. Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk
Notice of Interim Results
RNS
RNS Number : 6463M
UDG Healthcare Public Limited Co.
01 May 2018
1 May 2018
UDG Healthcare plc
Notice of Interim Results
UDG Healthcare plc ("the Group"), a leading international healthcare services provider, will issue its interim results for the half year ended 31 March 2018 at 07:00am (BST) on Tuesday 22 May 2018.